Integrated CDMO Sequel Medical operates as an integrated contract development and manufacturing organization (CDMO) with FDA registration and ISO13485 certification, presenting a compelling one-stop solution for medical device and life science customers seeking regulatory-compliant product development and manufacturing under OneSourceSolution.

OneSourceOpportunity Leverage the OneSourceSolution approach to target startups and established medical device firms needing streamlined concept-to-market support, potentially reducing time-to-market and regulatory risk through bundled services.

Mid-market Focus With 11-50 employees and annual revenue in the 1–10 million range, Sequel Medical sits in the mid-market segment ripe for growth through expanded contract manufacturing capacity, portfolio expansion, and larger, yet manageable, multi-project engagements.

HealthTech Synergy Position Sequel as a partner for devices spanning diagnostics, surgical tools, and life science applications, aligning with larger medical technology players who require reliable fabrication, regulatory compliance, and rapid iteration capabilities.

Tech and Process Alignment Highlight capabilities leveraging existing tech stack and quality systems to attract customers seeking robust documentation, traceability, and scalable production, while offering improvements or augmentations in digital tooling to enhance efficiency and GMP-ready output.